Market Research Logo

Global Plasma Therapeutics Market 2015-2019

Global Plasma Therapeutics Market 2015-2019

About plasma and plasma therapeutics

Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases. The separation of plasma from the blood is done by a process known as plasmapheresis. Plasma therapeutics are utilized in the treatment of rare, life-threatening, chronic, and genetic diseases, such as immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, and infectious diseases such as tetanus, hepatitis, and rabies.

Technavio's analysts forecast the global plasma therapeutics market to grow at a CAGR of 12.10% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global plasma therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.

Technavio's report, Global Plasma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global plasma therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key regions

  • Americas
  • APAC
  • EMEA
Key vendors
  • Baxter
  • CSL Behring
  • Grifols Therapeutics
  • Octapharma
Other prominent vendors
  • Abeona Therapeutics
  • ADMA Biologics
  • Amag Pharmaceuticals
  • Antares Pharma
  • BioDelivery Sciences
  • Bio Products Laboratory
  • Biota Pharmaceuticals
  • Biotest Pharmaceuticals
  • China Biologic Products
  • Depomed
  • Emergent BioSolutions
  • Ethicon
  • Flamel Technologies
  • Kamada
  • Kedrion
  • King Pharmaceuticals
  • Nektar Therapeutics
  • OMRIX Biopharmaceuticals
  • ProMetic Life Sciences
  • Rockwell Medical
  • The Medicines
  • ZymoGenetics
Key market driver
  • Growing demand for IVIG therapies
  • For a full, detailed list, view our report
Key market challenge
  • High cost of therapy
  • For a full, detailed list, view our report
Key market trend
  • Patient assistance programs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Plasma Therapeutics Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Plasma Therapeutics Market: Baxter, CSL Behring, Grifols Therapeutics, and Octapharma

Other Prominent Vendors in the market are: Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, China Biologic Products, Depomed, Emergent BioSolutions, Ethicon, Flamel Technologies, Kamada, Kedrion, King Pharmaceuticals, Nektar Therapeutics, OMRIX Biopharmaceuticals, ProMetic Life Sciences, Rockwell Medical, The Medicines, ZymoGenetics

Commenting on the report, an analyst from Technavio’s team said: “Patient assistance programs for plasma therapeutics are boosting the growth of the market. Vendors nowadays provide co-pay assistance to individuals who purchase plasma therapeutics.”

According to the report, IVIG is the largest segment of the plasma therapeutics market. IVIG is being increasingly used due to increases in the number of bleeding disorders, CIDP, and the global aging population. This has led to increased demand for IVIG therapeutics.



Further, the report states that the high cost of plasma therapeutics hinders market growth. Plasma protein therapies cost nearly four times more than other pharmaceutical medicines because of the use of expensive technologies in the manufacturing and processing of plasma-derived products.

Companies Mentioned

Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, China Biologic Products, Depomed, Emergent BioSolutions, Ethicon, Flamel Technologies, Kamada, Kedrion, King Pharmaceuticals, Nektar Therapeutics, OMRIX Biopharmaceuticals, ProMetic Life Sciences, Rockwell Medical, The Medicines, ZymoGenetics

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Plasma therapeutics: An overview:
    • Components of blood plasma
      • Table Composition of blood
      • Table Composition of plasma
    • Manufacturing process of plasma therapeutics
      • Table Total collection of plasma in US 2010-2014 (liters)
      • Table Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum)
      • Table Process of procurement and manufacturing of plasma therapeutics
    • Clinical uses of plasma
    • Cost of plasma therapeutics
  • Regulation of plasma therapeutics
    • Table Regulatory policies of plasma protein therapy lifecycle
    • Regulatory authorities
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global plasma therapeutics market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by products derived from plasma fractionation
    • Table Global plasma therapeutics market segment by-products derived from plasma fractionation
    • Human albumin
    • Plasma-derived coagulation factors
    • Immunoglobulins
    • Hyperimmune globulins
    • A1PI
    • Global human albumin market 2014-2019
      • Table Global human albumin market 2014-2019 ($ millions)
      • Table Key performance indicators in global albumin market
    • Global immunoglobulins market 2014-2019
      • Table Global immunoglobulins market 2014-2019 ($ millions)
      • Table Key performance indicators in global immunoglobulin market
    • Global A1PI market 2014-2019
      • Table Global A1PI market 2014-2019 ($ millions)
      • Table Key performance indicators in global A1PI market
  • Market segmentation by disease type
    • Table Global plasma therapeutics market segment by disease type
    • Clotting disorders
    • Immune disorders
    • AATD
    • Others
  • Geographical segmentation
    • Table Geographical segmentation of global plasma therapeutics market 2014
  • Market drivers
    • Table Drivers of global plasma therapeutics market
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Challenges in global plasma therapeutics market
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Global plasma therapeutics market share analysis 2014
      • Table YoY growth and revenue generated by plasma therapeutics 2011-2014 ($ millions)
      • Table YoY growth and revenue generate 2011-2014 ($ millions)
      • Table YoY growth and revenue of bioscience division 2011-2014 ($ millions)
      • Table Share of revenue by different divisions 2014
      • Table YoY growth and revenue of plasma therapeutics 2011-2014 ($ millions)
    • Other prominent vendors
  • Key vendor analysis
    • Baxter International
      • Table Baxter International : Business segmentation
      • Table Baxter International: Revenue by business segmentation 2013
      • Table Baxter International: Revenue by geographical segmentation 2013
    • CSL Behring
      • Table CSL Behring: Therapeutic areas segmentation 2013
      • Table CSL Behring: Product portfolio
      • Table CSL Behring: Geographical segmentation by revenue 2013
    • Grifols
      • Table Grifols: Business segmentation by revenue 2013
      • Table Grifols: Business segmentation by revenue 2012 and 2013 ($ billions)
      • Table Grifols: Geographical segmentation by revenue 2013
    • Octapharma
      • Table Octapharma: Product offerings
  • Appendix
    • List of abbreviation
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report